Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 27];10(2):s733. Available from: https://skin.dermsquared.com/skin/article/view/4026